Bank of Montreal’s SELLAS Life Sciences SLS Stock Holding History

Bank of Montreal’s Portfolio SLS Stock Details SLS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-1	Closed	-$2K	–	4169
2016 Q4	$2K	Buy	+1	New	+$5.82K	﹤0.01%	3898

Other funds holding SLS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Equitable Holdings New York $15.5B AUM 19.09% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Bank of Montreal's SLS Position: Q4 2021 in Review

Bank of Montreal sold out of SELLAS Life Sciences (SLS) in Q4 2021, closing a stake of 110,192 shares — an estimated $1.08M sold.

Bank of Montreal first reported a position in SLS in Q4 2016 and held it in 4 quarters. The position peaked at $1.43M in Q2 2021. 27 funds tracked by Wall St. Rank hold SLS as of Q4 2021.

Bank of Montreal reported no remaining SELLAS Life Sciences position as of Q4 2021 after selling out during the quarter.
Bank of Montreal sold 110,192 SELLAS Life Sciences shares in Q4 2021, an estimated $1.08M.
Bank of Montreal first reported a position in SELLAS Life Sciences in Q4 2016 and held it in 4 quarters.
Bank of Montreal's SELLAS Life Sciences position peaked at $1.43M in Q2 2021.
27 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q4 2021.

Based on Bank of Montreal's 13F filing for Q4 2021, filed 11 Feb 2022.